Vault-13

Lynx1 Capital Management LP

DORADO, PR · CIK 1910456 · 13F filing filed 2024-08-14

SEC-registered investment adviser since 2023 · limited partnership

As an employer

$277.2m reported value -28.6% vs Q1 2024
17positions
98.9%in top 10
7 new 5 added 3 reduced 6 sold out vs Q1 2024

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 MERUS N V COM MRUS MRUS 1,206,707 $71.4m25.76% 25.76% ReducedShares held: Q3 2023 1.2m, Q4 2023 1.1m, Q1 2024 1.5m, Q2 2024 1.2m -302.3k -302,300 -20.0%
2 STOKE THERAPEUTICS INC COM STOK STOK 5,185,191 $70.1m25.27% 25.27% AddedShares held: Q3 2023 1.7m, Q4 2023 3.0m, Q1 2024 3.7m, Q2 2024 5.2m +1.5m +1,488,371 40.3%
3 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 3,966,726 $46.3m16.69% 16.69% AddedShares held: Q3 2023 1.1m, Q4 2023 1.8m, Q1 2024 3.3m, Q2 2024 4.0m +656.2k +656,163 19.8%
4 C4 THERAPEUTICS INC COM STK CCCC CCCC 6,880,527 $31.8m11.47% 11.47% AddedShares held: Q3 2023 1.0m, Q4 2023 3.1m, Q1 2024 3.6m, Q2 2024 6.9m +3.2m +3,245,865 89.3%
5 TSCAN THERAPEUTICS INC COM TCRX TCRX 5,224,600 $30.6m11.03% 11.03% UnchangedShares held: Q3 2023 5.2m, Q4 2023 5.2m, Q1 2024 5.2m, Q2 2024 5.2m
6 CULLINAN THERAPEUTICS INC COM CGEM CGEM 377,323 $6.6m2.37% 2.37% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 377.3k
7 ALLOGENE THERAPEUTICS INC COM ALLO ALLO 2,228,295 $5.2m1.87% 1.87% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 2.2m
8 LONGBOARD PHARMACEUTICALS IN COM COM 167,317 $4.5m1.63% 1.63% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 167.3k
9 PASSAGE BIO INC COM COM 5,057,629 $4.0m1.45% 1.45% AddedShares held: Q3 2023 190.1k, Q4 2023 379.2k, Q1 2024 4.8m, Q2 2024 5.1m +211.8k +211,758 4.4%
10 CABALETTA BIO INC COM CABA CABA 492,103 $3.7m1.33% 1.33% ReducedShares held: Q3 2023 2.1m, Q4 2023 2.1m, Q1 2024 2.1m, Q2 2024 492.1k -1.6m -1,590,870 -76.4%
11 IBIO INC COM NEW IBIO IBIO 840,763 $1.8m0.64% 0.64% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 600.0k, Q2 2024 840.8k +240.8k +240,763 40.1%
12 BIONOMICS LIMITED ADS ADS 599,673 $459.9k0.17% 0.17% ReducedShares held: Q3 2023 815.5k, Q4 2023 824.3k, Q1 2024 814.5k, Q2 2024 599.7k -214.8k -214,794 -26.4%
13 PIERIS PHARMACEUTICALS INC COM NEW COM NEW 43,499 $426.8k0.15% 0.15% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 43.5k
14 KINIKSA PHARMACEUTICALS INTL ORD SHS CL A KNSA KNSA 9,500 $177.4k0.06% 0.06% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 9.5k
15 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 17,400 $157.1k0.06% 0.06% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 17.4k, Q2 2024 17.4k
16 KORRO BIO INC COM KRRO KRRO 3,800 $128.7k0.05% 0.05% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 3.8k
17 VYNE THERAPEUTICS INC COM COM 16,194 $31.9k0.01% 0.01% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 16.2k

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
ALPINE IMMUNE SCIENCES INC NVLS NVLS 2,253,183 $89.3m2.3m shares
SILENCE THERAPEUTICS PLC SLN SLN 526,642 $11.4m526.6k shares
AUTOLUS THERAPEUTICS PLC AUTL AUTL 1,390,160 $8.9m1.4m shares
KINNATE BIOPHARMA INC KNTE KNTE 1,981,106 $5.3m2.0m shares
NEKTAR THERAPEUTICS 2,068,842 $1.9m2.1m shares
PIERIS PHARMACEUTICALS INC 8,779,162 $1.6m8.8m shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
PASSAGE BIO INC 13D · filed 2026-07-02 21.0% +1.4 pts 13D 2026-07-02
GH RESEARCH PLC GHRS · 13G · filed 2026-08-14 GHRS 19.3%≈ $354.0m +1.9 pts 13G 2026-08-14
NEUPHORIA THERAPEUTICS INC NEUP · 13D · filed 2025-12-29 NEUP 16.3%≈ $3.8m no change 13D 2025-12-29
TSCAN THERAPEUTICS INC TCRX · 13G · filed 2026-08-14 TCRX 13.1%≈ $20.1m -1.9 pts 13G 2026-08-14
KORRO BIO INC KRRO · 13G · filed 2026-04-02 KRRO 10.7%≈ $20.3m +2.9 pts 13G 2026-04-02
C4 THERAPEUTICS INC CCCC · 13G · filed 2026-08-14 CCCC 10.0%≈ $63.1m +2.7 pts 13G 2026-08-14
CULLINAN THERAPEUTICS INC CGEM · 13G · filed 2025-11-14 CGEM 9.8%≈ $105.0m -4.7 pts 13G 2025-11-14
STOKE THERAPEUTICS INC STOK · 13G · filed 2026-08-14 STOK 6.5%≈ $132.1m -1.6 pts 13G 2026-08-14
IBIO INC IBIO · 13G · filed 2026-08-14 IBIO 5.4%≈ $4.9m +5.4 pts 13G 2026-08-14
PRECISION BIOSCIENCES INC DTIL · 13G · filed 2026-07-20 DTIL 5.4%≈ $10.9m +1.3 pts 13G 2026-07-20
AGIOS PHARMACEUTICALS INC AGIO · 13G · filed 2026-05-06 AGIO 5.1%≈ $111.8m new 13G 2026-05-06